Matthew Eybs YOU? Author Swipe

Last 10y

Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis Open

Rita Spathis, Deeva Robles Kuriplach, Sabrina Narvesen, Matthew Eybs, Karen Huang , et al. · 2025

[This corrects the article DOI: 10.3389/fimmu.2025.1527840.].

Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis Open

Rita Spathis, Deeva Robles Kuriplach, Sabrina Narvesen, Matthew Eybs, Karen Huang , et al. · 2025

Background Inefficient transduction is a major limitation in achieving therapeutic levels of AAV-delivered microdystrophin capable of improving muscle function in patients with Duchenne muscular dystrophy. Additionally, some patients exper…